Showing results (121-130 of 4,697) with videos related to
Sort By:
Pageof 470
Seminars in Oncology|December 6, 2006
Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse eventsHerbert Hurwitz, Shermini SainiSeminars in Oncology|December 6, 2006
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practiceChristopher G Willett, Sergey V Kozin, Dan G Duda, et al.Seminars in Oncology|December 21, 2006
Biomarkers of response to preoperative chemoradiation in esophageal cancersRajyalakshmi Luthra, Madan G Luthra, Julie Izzo, et al.Seminars in Oncology|December 21, 2006
Molecular biology of colorectal cancer: new targetsKrit Kitisin, Lopa MishraSeminars in Oncology|December 21, 2006
Planned treatment interruptions and chemotherapy-free intervals in the treatment of metastatic colorectal cancer: time to start stopping?Leonard SaltzSeminars in Oncology|December 21, 2006
The angiogenic switch molecule, secreted FGF-binding protein, an indicator of early stages of pancreatic and colorectal adenocarcinomaElena Tassi, Anton WellsteinSeminars in Oncology|December 21, 2006
Functional imaging for early prediction of response to chemoradiotherapy: 3'-deoxy-3'-18F-fluorothymidine positron emission tomography--a clinical application model of esophageal cancerK S Clifford ChaoSeminars in Oncology|December 21, 2006
Should preoperative or postoperative therapy be administered in the management of rectal cancer?Lisa A KachnicSeminars in Oncology|October 1, 1991
The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinomaR A Figlin, A S Abi-Aad, A Belldegrun, et al.Pageof 470